Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
暂无分享,去创建一个
T. Kanno | N. Nagata | Tadaki Suzuki | H. Hasegawa | Shinji Saito | R. Suzuki | M. Tobiume | A. Ainai | N. Iwata-Yoshikawa | K. Sano | T. Hashiguchi | Sho Miyamoto | S. Iida | T. Hemmi | Yuko Sato | A. Ueno | N. Shiwa-Sudo | Koji Tamura